Anupam Rasayan appoints Ravi Desai as chief operating officer

1 min read     Updated on 14 Aug 2026, 10:20 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Anupam Rasayan India Limited promoted Ravi Desai from Sales Head to Chief Operating Officer effective August 14, 2026. The Board approved the move during its meeting on that date. Desai, a KMP with the company since 2012, brings over two decades of experience in specialty chemicals, covering sales, marketing, and plant operations.

powered bylight_fuzz_icon
48228616

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited has appointed Ravi Desai as Chief Operating Officer, effective August 14, 2026. The Board of Directors approved the appointment during a meeting held on the same date, following the recommendation of the Nomination and Remuneration Committee.

Desai continues in his capacity as a Key Managerial Personnel (KMP) of the company. He previously held the position of Sales Head at Anupam Rasayan.

Leadership Transition

The appointment marks an internal promotion for Desai, who has been associated with the company since 2012. His new role expands his responsibilities beyond sales to include broader operational oversight.

Desai holds a Master of Computer Applications (MCA) from Bharati Vidyapeeth University, Pune, and a Bachelor of Science (B.Sc.) degree from Veer Narmad South Gujarat University, Surat.

Operational Scope

With over 20 years of experience in the specialty chemicals industry, Desai’s tenure at Anupam Rasayan will now encompass business development, strategic planning, customer relationship management, and commercial and plant operations.

His previous leadership in Sales and Marketing contributed to the company’s growth across its diversified portfolio, which includes:

  • Specialty chemicals for crop protection
  • Personal care ingredients
  • Pharmaceuticals
  • Performance materials, including polymer and electronic chemicals

The company highlighted Desai’s collaboration with manufacturing, supply chain, research and development, and finance teams to ensure effective execution of business strategies and timely delivery of customer commitments.

Regulatory Disclosure

The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Detailed information regarding the appointment is available in Annexure-A of the filing issued under SEBI Master Circular no. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026, dated January 30, 2026.

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
+0.76%+0.33%-4.15%-8.93%+6.12%+61.37%

How might Ravi Desai's expanded operational oversight influence Anupam Rasayan's supply chain efficiency and cost management strategies in the coming fiscal year?

What specific growth targets or market expansion plans has the company outlined to leverage Desai's dual expertise in sales and plant operations?

Could this internal promotion signal a shift in corporate governance or succession planning for other Key Managerial Personnel roles at Anupam Rasayan?

Anupam Rasayan Q1FY27 revenue up 35%, profit dips 11% YoY

2 min read     Updated on 14 Aug 2026, 10:08 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Anupam Rasayan India Limited posted Q1FY27 consolidated revenue of ₹6,549.80 million, up 35% YoY, while net profit fell 11% to ₹386.39 million. EBITDA rose 30% to ₹1,620 million, but margins slipped to 24.8% from 25.6% due to rising employee and finance costs.

powered bylight_fuzz_icon
48227773

*this image is generated using AI for illustrative purposes only.

Anupam Rasayan India Limited reported significant top-line growth for the first quarter of FY27, with consolidated revenue from operations expanding by 35% year-on-year to ₹6,549.80 million. This compares to ₹4,858.27 million in the corresponding period of FY25. Despite the robust revenue expansion, consolidated net profit attributable to owners dipped 11% to ₹386.39 million, down from ₹426.50 million in Q4FY26 and lower than the ₹340.36 million recorded in Q1FY25.

Operating profitability showed mixed signals. Consolidated EBITDA rose 30% year-on-year to ₹1,620 million (₹1.62 billion), up from ₹1,240 million (₹1.24 billion) in Q1FY25. However, the EBITDA margin contracted to 24.8% from 25.6% in the previous year, indicating that cost pressures outpaced revenue growth. Standalone revenue also grew 4% year-on-year to ₹3,288.05 million, while standalone PAT increased 8% to ₹320.06 million.

Financial Performance Highlights

Metric Q1FY27 (₹m) Q4FY26 (₹m) Q1FY26 (₹m) YoY Change
Consolidated Revenue 6,549.80 6,357.83 4,858.27 +35%
Consolidated PAT (Owners) 386.39 426.50 340.36 -11%
Consolidated EBITDA 1,620.00 N/A 1,240.00 +30%
Standalone Revenue 3,288.05 3,705.79 3,156.94 +4%
Standalone PAT 320.06 423.84 296.94 +8%

On a standalone basis, basic earnings per share were reported at ₹2.81, compared to ₹2.70 in the corresponding quarter last year. Total comprehensive income for the group rose to ₹514.93 million from ₹476.39 million a year ago.

What the Numbers Show

A notable divergence exists between the company’s revenue growth and its profitability metrics. While consolidated revenue surged by over 35% year-on-year, employee benefit expenses more than tripled to ₹648.84 million from ₹203.31 million in Q1FY25. This sharp rise in personnel costs, alongside an increase in finance costs to ₹491.92 million from ₹356.65 million, contributed to the compression in net margins despite robust top-line expansion. The data suggests that operational scaling is currently accompanied by disproportionate increases in fixed cost structures, leading to a slight contraction in EBITDA margin from 25.6% to 24.8%.

Board Appointments and Governance

During its meeting on August 14, 2026, the Board of Directors approved the unaudited financial results for both standalone and consolidated entities. The board also appointed Mr. Ravi Desai as Chief Operating Officer, effective immediately, while he continues to serve as a Key Managerial Personnel.

The unaudited interim results were reviewed by Natvarlal Vepari & Co., Chartered Accountants, Surat, in accordance with Standard on Review Engagements (SRE) 2410. The consolidated results include subsidiaries such as Jainam Intermediates Private Limited and Tanfac Industries Limited, as well as associate Tangent Science Private Limited.

Historical Stock Returns for Anupam Rasayan

1 Day5 Days1 Month6 Months1 Year5 Years
+0.76%+0.33%-4.15%-8.93%+6.12%+61.37%

Will Anupam Rasayan implement specific cost-control measures to reverse the EBITDA margin contraction from 25.6% to 24.8% in the upcoming quarters?

How will the appointment of Mr. Ravi Desai as COO influence the company's operational efficiency and management of rising employee benefit expenses?

Is the 35% revenue growth driven by volume expansion or price increases, and how sustainable is this trajectory given current chemical sector demand trends?

More News on Anupam Rasayan

1 Year Returns:+6.12%